𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Methotrexate in the treatment of penile carcinoma

✍ Scribed by Robert B. Sklaroff; Alan Yagoda

Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
299 KB
Volume
45
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Weekly intravenous methotrexate in the t
Weekly intravenous methotrexate in the treatment of rheumatoid arthritis
✍ Dr. Robert M. Michaels; David J. Nashel; Andrea Leonard; Anthony J. Sliwinski; S πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 279 KB

Patients with rheumatoid arthritis who are unresponsive to antiinflammatory drugs and slow-acting agents such as gold, hydroxychloroquine, and Dpenicillamine, pose a therapeutic challenge. This report details the effectiveness of weekly intravenous methotrexate in 14 such patients resistant to stand

Sequential methotrexate–5-fluorouracil t
Sequential methotrexate–5-fluorouracil treatment of squamous cell carcinoma of the head and neck
✍ Ulrik Ringborg; GΓ–Sta Ewert; Jan Kinnman; Per-Gotthard Lundqvist; Hans Strander πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 271 KB πŸ‘ 2 views

Thirty-six patients with squamous cell carcinoma of the head and neck were treated with sequential methotrexate-5-fluorouracil followed by leucovorin rescue. The frequency of objective tumor regression obtained was 64% (complete response + partial response) with 19% complete regression. In 20 not pr

A Phase II trial of methotrexate, vinbla
A Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix
✍ Christos A. Papadimitriou; Meletios A. Dimopoulos; Nikolaos Giannakoulis; Kyrill πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 68 KB πŸ‘ 2 views

## Background: Patients with metastatic carcinoma of the uterine cervix have limited survival. thus, new chemotherapeutic agents and combinations are needed to improve patient outcome. ## Methods: Twenty-seven patients with stage iv primary or recurrent carcinoma of the uterine cervix were assign